Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.
about
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrineFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansMisframed ubiquitin and impaired protein quality control: an early event in Alzheimer's diseaseREM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in ParticularNeuroinflammation in Alzheimer's diseaseAPP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer's diseaseβ1-adrenergic receptor activation enhances memory in Alzheimer's disease modelNeural Consequences of Chronic Short Sleep: Reversible or Lasting?A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the ratBehavioral phenotyping of mouse models of Parkinson's disease.Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice.Recruiting adaptive cellular stress responses for successful brain ageing.Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease.Degenerative alterations in noradrenergic neurons of the locus coeruleus in Alzheimer's diseaseEar2 deletion causes early memory and learning deficits in APP/PS1 mice.Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse modelsVMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease.The sleep-wake cycle and Alzheimer's disease: what do we know?Wake-active neurons across aging and neurodegeneration: a potential role for sleep disturbances in promoting disease.Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis.Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice.Localization of mutant ubiquitin in the brain of a transgenic mouse line with proteasomal inhibition and its validation at specific sites in Alzheimer's diseaseAmyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neuronsIntraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenesNoradrenergic dysfunction in Alzheimer's disease.Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells.Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.Age-related neurodegeneration and memory loss in down syndrome.Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes.Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.Administration of NaHS Attenuates Footshock-Induced Pathologies and Emotional and Cognitive Dysfunction in Triple Transgenic Alzheimer's Mice.The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demandSelective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 miceNorepinephrine Protects against Amyloid-β Toxicity via TrkB.The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease
P2860
Q22248084-6611DA0B-9DA5-4425-BA5A-88285A5F0F6DQ24654140-DAEEDEE5-BA33-4B3C-AAFF-4CBAD8C8A0BEQ26782999-A0655F1B-6C2A-4EC4-9B89-296899894D7FQ28073069-F260B559-8C25-4485-9DBE-750608CEA84FQ28259238-489FE05E-8A2E-4DB3-8BDF-2ACF7976B210Q30455082-D206AC6C-D239-496A-BB65-72327917DB42Q30544139-A199B919-727E-44CA-AE20-1EFAB95E40CFQ31143998-88872120-5F6C-4588-B3D0-2D377BC25985Q33678421-419270C8-26C6-4BD9-B8D1-20AA85DD648AQ33740537-005995CD-D758-4235-A51A-43AB7757E191Q33768657-15384E73-637F-418D-BC95-8AFECCB7237FQ33820609-C28A2FF3-A302-4E2B-B3DF-1A6E77A545AAQ33830725-8F342C7E-41E1-4D32-8043-E51AD6DFBD98Q33854353-2B6EBF01-3951-4F47-A43E-4E53B4CC0B7DQ33942884-B1C29941-9950-4558-8B63-6E5BDCB52D18Q34095163-E690771A-8E62-4AE1-B408-326BB33BCBB5Q34101988-3AABC8E8-1A1C-4652-8DAB-67328DDFFA06Q34391616-85F0FC47-74BC-4143-8FBF-9DD100F048EFQ34418781-DFB06895-BE93-4E41-9DEB-21EA503989F0Q34595165-7F1AA271-7C9D-48FD-B73B-804B3D5DA2EBQ34637928-3A04AB41-0D39-4C51-8DE7-72C263E02B6DQ35014204-08CD6484-C5F0-4C3D-A7AC-D8272A21662AQ35018088-E3D925F2-38CA-43A6-90F2-B48D284615C8Q35053378-FAB4119C-A272-46B7-814E-F31E8FD4162AQ35184113-C092AD2F-9923-4946-9766-E43A69AA814BQ35213182-70517853-D94E-4138-90C8-09C3951203D1Q35246412-97701C98-454E-4E81-B2B5-D07069C5FFC4Q35663346-C37A4C0B-C52E-40CE-9A17-8B30B5F1A0BFQ35749478-C4CEB73A-C623-4005-B85A-541240088D75Q35812335-450D94E3-D428-42D5-A324-14A17B895C6DQ35838504-AE841270-D79B-4EDA-AFBD-E8A64D071389Q35867093-AD6F9B73-1D98-47FD-AF2D-0C43931AA2B4Q36035950-00DEC4B8-C379-49A9-8AF9-36442CFD2130Q36103023-ED401107-A5B7-4667-9C16-1502A975B1A2Q36105261-BF4ABD64-46DA-4C8C-A332-08F19249B72BQ36316228-F8CC7B79-B46C-4D68-94B8-905378B30A4DQ36459060-3ADBEBFE-98CE-4D29-A2EA-006D1BC96065Q36462902-E52E4617-228D-49C1-BA09-02EF5688BF9DQ36467129-910D3B09-4AC2-4C09-845A-73B564889B5BQ36822309-5062C21A-E54C-4ABB-B375-177B8CE0E535
P2860
Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@ast
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@en
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@nl
type
label
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@ast
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@en
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@nl
prefLabel
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@ast
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@en
Locus ceruleus degeneration pr ...... or protein 23 transgenic mice.
@nl
P2093
P50
P1476
Locus ceruleus degeneration pr ...... sor protein 23 transgenic mice
@en
P2093
Andras Bilkei-Gorzo
Andreas H Jacobs
Andreas Zimmer
Lucia Dumitrescu-Ozimek
Magdalena Sastre
Mathias Hoehn
Michael T Heneka
Mutiah Ramanathan
Norbert Galldiks
Thomas Debeir
P304
P356
10.1523/JNEUROSCI.4236-05.2006
P407
P577
2006-02-01T00:00:00Z